AQP1 and myeloid sarcoma: Retrospective analysis of the available MRI and clinical data was possible for 22 patients positive only for anti-AQP1 antibodies (17 suspected NMOsd patients among the seropositives in the 1st column of Figure 1 and the 5 seropositive MS patients in the 3rd column of Figure 1).